Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Noxious as well as hypertonic stimuli potentiate vasopressin and
oxytocin
secretion in rats. Neurohypophysial vasopressin- and
oxytocin
-secreting neurons receive inhibitory synaptic inputs mediated by gamma-aminobutyric acid (GABA). Benzodiazepines modulate GABA-A receptor activity in a facilitatory fashion. It is thus possible that benzodiazepines suppress vasopressin and
oxytocin
release after noxious stimuli. To test this hypothesis, we investigated whether chlordiazepoxide impairs the enhanced release of vasopressin and
oxytocin
after noxious or hypertonic stimuli in male rats.
Chlordiazepoxide
(5-20 mg/kg, i.p.) blocked dose-dependently the vasopressin and
oxytocin
responses to footshocks.
Chlordiazepoxide
, however, did not impair the hormonal responses to hypertonic stimulus. The results demonstrate that chlordiazepoxide selectively prevents vasopressin and
oxytocin
release after noxious stimuli and therefore suggest that the sites of chlordiazepoxide actions are not on the vasopressin or
oxytocin
neurons in rats.
...
PMID:A benzodiazepine, chlordiazepoxide, blocks vasopressin and oxytocin release after footshocks but not osmotic stimulus in the rat. 874 44